Annual Cash & Cash Equivalents
$23.68 M
-$38.94 M-62.18%
31 December 2023
Summary:
VBI Vaccines annual cash & cash equivalents is currently $23.68 million, with the most recent change of -$38.94 million (-62.18%) on 31 December 2023. During the last 3 years, it has fallen by -$70.14 million (-74.76%).VBIV Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$12.60 M
-$11.09 M-46.82%
31 March 2024
Summary:
VBI Vaccines quarterly cash and cash equivalents is currently $12.60 million, with the most recent change of -$11.09 million (-46.82%) on 31 March 2024. Over the past year, it has dropped by -$22.86 million (-64.48%).VBIV Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBIV Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -62.2% | -64.5% |
| 3 y3 years | -74.8% | -90.8% |
| 5 y5 years | -60.0% | -76.2% |
VBIV Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -80.5% | -90.8% |
VBI Vaccines Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $12.60 M(-46.8%) |
| Dec 2023 | $23.68 M(-62.2%) | $23.68 M(-33.2%) |
| Sept 2023 | - | $35.45 M(+70.1%) |
| June 2023 | - | $20.84 M(-48.4%) |
| Mar 2023 | - | $40.39 M(-35.5%) |
| Dec 2022 | $62.63 M(-48.5%) | $62.63 M(-25.0%) |
| Sept 2022 | - | $83.55 M(+1.4%) |
| June 2022 | - | $82.41 M(-18.7%) |
| Mar 2022 | - | $101.34 M(-16.7%) |
| Dec 2021 | $121.69 M(+29.7%) | $121.69 M(-11.5%) |
| Sept 2021 | - | $137.47 M(+1.8%) |
| June 2021 | - | $135.03 M(+24.8%) |
| Mar 2021 | - | $108.23 M(+15.3%) |
| Dec 2020 | $93.83 M(+112.2%) | $93.83 M(-1.4%) |
| Sept 2020 | - | $95.16 M(+55.9%) |
| June 2020 | - | $61.03 M(+70.5%) |
| Mar 2020 | - | $35.80 M(-19.0%) |
| Dec 2019 | $44.21 M(-25.4%) | $44.21 M(-16.6%) |
| Sept 2019 | - | $53.02 M(+76.3%) |
| June 2019 | - | $30.07 M(-30.6%) |
| Mar 2019 | - | $43.31 M(-26.9%) |
| Dec 2018 | $59.27 M(-12.4%) | $59.27 M(+128.1%) |
| Sept 2018 | - | $25.99 M(-36.8%) |
| June 2018 | - | $41.13 M(-29.2%) |
| Mar 2018 | - | $58.09 M(-14.2%) |
| Dec 2017 | $67.69 M(+109.7%) | $67.69 M(+573.3%) |
| Sept 2017 | - | $10.05 M(-35.7%) |
| June 2017 | - | $15.64 M(-33.5%) |
| Mar 2017 | - | $23.51 M(-27.2%) |
| Dec 2016 | $32.28 M(+158.8%) | $32.28 M(+93.1%) |
| Sept 2016 | - | $16.71 M(-23.4%) |
| June 2016 | - | $21.81 M(+99.0%) |
| Mar 2016 | - | $10.96 M(-12.2%) |
| Dec 2015 | $12.48 M(-53.4%) | $12.48 M(-22.1%) |
| Sept 2015 | - | $16.01 M(-40.0%) |
| June 2015 | - | $26.70 M(-0.2%) |
| Mar 2015 | - | $26.76 M(-10.2%) |
| Mar 2015 | $26.76 M(-29.0%) | - |
| Dec 2014 | - | $29.81 M(-14.9%) |
| Sept 2014 | - | $35.03 M(-6.7%) |
| June 2014 | - | $37.54 M(-0.5%) |
| Mar 2014 | $37.71 M(-22.2%) | $37.71 M(-7.7%) |
| Dec 2013 | - | $40.87 M(-7.0%) |
| Sept 2013 | - | $43.94 M(-0.9%) |
| June 2013 | - | $44.32 M(-8.6%) |
| Mar 2013 | $48.47 M(-16.7%) | $48.47 M(-8.5%) |
| Dec 2012 | - | $52.97 M(-2.9%) |
| Sept 2012 | - | $54.58 M(-0.9%) |
| June 2012 | - | $55.05 M(-5.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | $58.19 M(+184.9%) | $58.19 M(-2.3%) |
| Dec 2011 | - | $59.57 M(-3.3%) |
| Sept 2011 | - | $61.59 M(-10.2%) |
| June 2011 | - | $68.58 M(+235.8%) |
| Mar 2011 | $20.42 M(+930.2%) | $20.42 M(+45.1%) |
| Dec 2010 | - | $14.08 M(+10.1%) |
| Sept 2010 | - | $12.79 M(+1507.4%) |
| June 2010 | - | $795.40 K(-59.9%) |
| Mar 2010 | $1.98 M(+746.5%) | $1.98 M(-23.8%) |
| Dec 2009 | - | $2.60 M(+734.1%) |
| Sept 2009 | - | $311.70 K(+79.0%) |
| June 2009 | - | $174.10 K(-25.7%) |
| Mar 2009 | $234.20 K(+8.9%) | $234.20 K(+76.5%) |
| Dec 2008 | - | $132.70 K(-29.0%) |
| Sept 2008 | - | $187.00 K(-40.6%) |
| June 2008 | - | $314.60 K(+46.3%) |
| Mar 2008 | $215.00 K(-60.5%) | $215.00 K(-41.1%) |
| Dec 2007 | - | $365.20 K(-37.3%) |
| Sept 2007 | - | $582.90 K(-22.2%) |
| June 2007 | - | $748.90 K(+37.4%) |
| Mar 2007 | $544.90 K(-13.3%) | $544.90 K(+33.3%) |
| Dec 2006 | - | $408.90 K(-2.8%) |
| Sept 2006 | - | $420.80 K(-40.7%) |
| June 2006 | - | $709.70 K(+12.9%) |
| Mar 2006 | $628.60 K(+3157.0%) | $628.60 K(+746.0%) |
| Dec 2005 | - | $74.30 K(+658.2%) |
| Sept 2005 | - | $9800.00(-74.4%) |
| June 2005 | - | $38.30 K(+98.4%) |
| Mar 2005 | $19.30 K(-90.4%) | $19.30 K(-94.8%) |
| Dec 2004 | - | $373.80 K(-1.2%) |
| Sept 2004 | - | $378.50 K(-21.0%) |
| June 2004 | - | $479.30 K(+138.0%) |
| Mar 2004 | $201.40 K(+170.3%) | $201.40 K(-22.8%) |
| Dec 2003 | - | $260.90 K(+231.5%) |
| Sept 2003 | - | $78.70 K(-47.0%) |
| June 2003 | - | $148.50 K(+99.3%) |
| Mar 2003 | $74.50 K(+3447.6%) | $74.50 K(+6108.3%) |
| Dec 2002 | - | $1200.00(+500.0%) |
| Sept 2002 | - | $200.00(-92.3%) |
| June 2002 | - | $2600.00(+23.8%) |
| Mar 2002 | $2100.00(+250.0%) | $2100.00(+600.0%) |
| Dec 2001 | - | $300.00(-25.0%) |
| Sept 2001 | - | $400.00(-60.0%) |
| June 2001 | - | $1000.00(+66.7%) |
| Mar 2001 | $600.00(-99.6%) | $600.00(-87.0%) |
| Dec 2000 | - | $4600.00(-86.3%) |
| Sept 2000 | - | $33.50 K(>+9900.0%) |
| Dec 1997 | - | $0.00 |
| Mar 1997 | $144.90 K | - |
FAQ
- What is VBI Vaccines annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for VBI Vaccines?
- What is VBI Vaccines annual cash & cash equivalents year-on-year change?
- What is VBI Vaccines quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for VBI Vaccines?
- What is VBI Vaccines quarterly cash and cash equivalents year-on-year change?
What is VBI Vaccines annual cash & cash equivalents?
The current annual cash & cash equivalents of VBIV is $23.68 M
What is the all time high annual cash & cash equivalents for VBI Vaccines?
VBI Vaccines all-time high annual cash & cash equivalents is $121.69 M
What is VBI Vaccines annual cash & cash equivalents year-on-year change?
Over the past year, VBIV annual cash & cash equivalents has changed by -$38.94 M (-62.18%)
What is VBI Vaccines quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of VBIV is $12.60 M
What is the all time high quarterly cash and cash equivalents for VBI Vaccines?
VBI Vaccines all-time high quarterly cash and cash equivalents is $137.47 M
What is VBI Vaccines quarterly cash and cash equivalents year-on-year change?
Over the past year, VBIV quarterly cash and cash equivalents has changed by -$22.86 M (-64.48%)